• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者的外周免疫细胞:疾病进展的窥探孔。

Peripheral immune cells in NAFLD patients: A spyhole to disease progression.

机构信息

Department of Gastroenterology, Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Gastroenterology, Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai, China.

出版信息

EBioMedicine. 2022 Jan;75:103768. doi: 10.1016/j.ebiom.2021.103768. Epub 2021 Dec 17.

DOI:10.1016/j.ebiom.2021.103768
PMID:34929490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8693289/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a worldwide leading cause of chronic liver disease, but we still lack ideal non-invasive tools for diagnosis and evaluation of nonalcoholic steatohepatitis (NASH) and related liver fibrosis in NAFLD population. Systemic immune dysregulations such as metabolic inflammation are believed to play central role in the development of NAFLD, signifying the hope of utilizing quantitative and phenotypic changes in peripheral immune cells among NAFLD patients as a diagnostic tool of NASH and fibrosis. In this review, we summarize the known changes in peripheral immune cells from NAFLD/NASH patients and their potential relationship with NAFLD and NASH progression. Potential challenges and possible solutions for further clinical translation are also discussed.

摘要

非酒精性脂肪性肝病(NAFLD)是全球范围内导致慢性肝病的主要原因,但我们仍然缺乏理想的非侵入性工具来诊断和评估非酒精性脂肪性肝炎(NASH)和 NAFLD 人群中的相关肝纤维化。全身性免疫失调,如代谢性炎症,被认为在 NAFLD 的发展中起核心作用,这表明有希望利用 NAFLD 患者外周免疫细胞的数量和表型变化作为 NASH 和纤维化的诊断工具。在这篇综述中,我们总结了 NAFLD/NASH 患者外周免疫细胞的已知变化及其与 NAFLD 和 NASH 进展的潜在关系。还讨论了进一步临床转化的潜在挑战和可能的解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af3/8693289/5001af5ca713/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af3/8693289/e0d078fef4b9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af3/8693289/5001af5ca713/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af3/8693289/e0d078fef4b9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af3/8693289/5001af5ca713/gr2.jpg

相似文献

1
Peripheral immune cells in NAFLD patients: A spyhole to disease progression.非酒精性脂肪性肝病患者的外周免疫细胞:疾病进展的窥探孔。
EBioMedicine. 2022 Jan;75:103768. doi: 10.1016/j.ebiom.2021.103768. Epub 2021 Dec 17.
2
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比,不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
3
Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.雌激素在非酒精性脂肪性肝病/非酒精性脂肪性肝炎性别差异中的潜在治疗应用。
Cells. 2019 Oct 15;8(10):1259. doi: 10.3390/cells8101259.
4
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
5
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.非酒精性脂肪性肝病:从非酒精性脂肪性肝病到非酒精性脂肪性肝炎的进展中的基本发病机制。
Transplantation. 2019 Jan;103(1):e1-e13. doi: 10.1097/TP.0000000000002480.
6
Immune-metabolic interactions in homeostasis and the progression to NASH.免疫代谢相互作用在稳态和进展为 NASH 中的作用。
Trends Endocrinol Metab. 2022 Oct;33(10):690-709. doi: 10.1016/j.tem.2022.07.001. Epub 2022 Aug 10.
7
Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的免疫相关发病机制和治疗策略。
Arch Pharm Res. 2022 Apr;45(4):229-244. doi: 10.1007/s12272-022-01379-1. Epub 2022 Apr 7.
8
Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances.脂质组学在非酒精性脂肪性肝炎(NASH)发病机制、进展和治疗中的作用:最新进展。
Prog Lipid Res. 2023 Jul;91:101238. doi: 10.1016/j.plipres.2023.101238. Epub 2023 May 25.
9
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
10
STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease.在非酒精性脂肪性肝病患者中,单核细胞来源的巨噬细胞中 STING 的表达与肝脏炎症和纤维化的进展相关。
Lab Invest. 2020 Apr;100(4):542-552. doi: 10.1038/s41374-019-0342-6. Epub 2019 Nov 19.

引用本文的文献

1
Prognostic impact of systemic inflammation indicators on all-cause and CVD mortality in adults with MASLD.全身炎症指标对患有代谢相关脂肪性肝病的成年人全因死亡率和心血管疾病死亡率的预后影响。
BMC Gastroenterol. 2025 Jul 1;25(1):448. doi: 10.1186/s12876-025-04018-3.
2
Single-cell landscape of peripheral immune cells in MASLD/MASH.代谢相关脂肪性肝病/非酒精性脂肪性肝炎中外周免疫细胞的单细胞图谱
Hepatol Commun. 2025 Apr 21;9(5). doi: 10.1097/HC9.0000000000000643. eCollection 2025 May 1.
3
Dynamic Status of Systemic Immune Inflammation Index Is Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: An Evidence From a Ten-Year Prospective Longitudinal Cohort Study.
全身免疫炎症指数的动态状态与代谢功能障碍相关脂肪性肝病有关:一项十年前瞻性纵向队列研究的证据
J Inflamm Res. 2025 Apr 1;18:4595-4606. doi: 10.2147/JIR.S509814. eCollection 2025.
4
The Yin-Yang functions of macrophages in metabolic disorders.巨噬细胞在代谢紊乱中的阴阳功能。
Life Med. 2022 Aug 30;1(3):319-332. doi: 10.1093/lifemedi/lnac035. eCollection 2022 Dec.
5
Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis.外周血单个核细胞中线粒体融合失衡与代谢功能障碍相关脂肪性肝炎患者的肝纤维化有关。
Heliyon. 2024 Mar 8;10(6):e27557. doi: 10.1016/j.heliyon.2024.e27557. eCollection 2024 Mar 30.
6
A review of experimental and clinical studies on the therapeutic effects of pomegranate () on non-alcoholic fatty liver disease: Focus on oxidative stress and inflammation.石榴对非酒精性脂肪性肝病治疗作用的实验与临床研究综述:聚焦氧化应激与炎症
Food Sci Nutr. 2023 Sep 21;11(12):7485-7503. doi: 10.1002/fsn3.3713. eCollection 2023 Dec.
7
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease.代谢相关脂肪性肝病中双向免疫交叉对话。
Cell Metab. 2023 Nov 7;35(11):1852-1871. doi: 10.1016/j.cmet.2023.10.009.
8
Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern.基于外周血淋巴细胞模式无创性方法预测非酒精性脂肪性肝炎重叠自身免疫性肝炎的危险因素。
J Gastroenterol. 2023 Dec;58(12):1237-1251. doi: 10.1007/s00535-023-02038-y. Epub 2023 Sep 14.
9
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease.SARS-CoV-2 与肝脏:慢性肝病的临床和免疫学特征。
Gut. 2023 Sep;72(9):1783-1794. doi: 10.1136/gutjnl-2023-329623. Epub 2023 Jun 14.
10
Synergistic Effect of Diet and Physical Activity on a NAFLD Cohort: Metabolomics Profile and Clinical Variable Evaluation.饮食与体力活动对非酒精性脂肪性肝病队列的协同作用:代谢组学特征和临床变量评估。
Nutrients. 2023 May 25;15(11):2457. doi: 10.3390/nu15112457.